Retrospective Cohort Study
Copyright ©The Author(s) 2018.
World J Transplantation. Sep 10, 2018; 8(5): 178-187
Published online Sep 10, 2018. doi: 10.5500/wjt.v8.i5.178
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Survival Kaplan-Meier curves following diagnosis in PE-IVIG-RTX and control groups. A: Graft survival; B: Graft survival (death-censored).
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Serum creatinine, glomerular filtration rate and proteinuria at diagnosis. A: Serum creatinine at diagnosis (12 and 24 mo); B: Glomerular filtration rate at diagnosis (12 and 24 mo); C: Proteinuria at diagnosis (12 and 24 mo).
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Glomerular filtration rate in functioning and non-functioning grafts at 24 mo and follow-up. A: PE-IVIG-RTX group; B: Control group.
  • Citation: Mella A, Gallo E, Messina M, Caorsi C, Amoroso A, Gontero P, Verri A, Maletta F, Barreca A, Fop F, Biancone L. Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results. World J Transplantation 2018; 8(5): 178-187
  • URL: https://www.wjgnet.com/2220-3230/full/v8/i5/178.htm
  • DOI: https://dx.doi.org/10.5500/wjt.v8.i5.178